IFI-M · CUS Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01887 // MULTI-AXIS · IFI-M

CUS Tri-Axis Dominant-Primary Series III-BL

Mentha × piperita

Peppermint

Tier IIICUS Tri-Axis Dominant-Primary Series

Target Trait

1.95×

fold-change

Cooling-dominant tri-axis U+S modulated fold-change

Technical Specifications

SKU

SS-F-M3-01887

Genomic Edits

10

GC Content

46%

Construct Length

5,864 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPM8 + mGluR1 + TAS1R2/TAS1R3

IFI Score

195

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CUS pathway operation
  • Cross-pathway regulatory circuit for cooling-dominant CUS triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and TAS1R2/TAS1R3 pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CUS) with cross-pathway flux managementBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III CUS triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?